Insmed, Inc. (INSM) Reports Q4 Earnings of $0.30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $93.39 -1.76%
EPS Growth %: +77.7%
Financial Fact:
Net loss: -37.76M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +77.7%
Financial Fact:
Net loss: -37.76M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Insmed, Inc. (NASDAQ: INSM) reported Q4 EPS of $0.30, versus $0.42 reported last year. Revenue for the quarter came in at $1.4 million, versus $6.9 million reported last year.
For earnings history and earnings-related data on Insmed, Inc. (INSM) click here.
For earnings history and earnings-related data on Insmed, Inc. (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- RBC Capital Reiterates Outperform Rating on Verisk Analytics (VRSK)
- Wells Fargo Names Top Pick Ahead of Q3 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
